Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
13151
CALL
Quadratic Deflation ETF
BNDD
$12.7M
| $10.1K | ﹤0.01% |
88
+63
| +252% | +$7.37K |
2024 Q2
1 quarter
|
|
|
WPRT
13152
PUT
Westport Fuel Systems
WPRT
$35.6M
| $10.1K | ﹤0.01% |
2,200
+1,400
| +175% | +$7.83K |
2013 Q2
45 quarters
|
|
13153
CALL
CXApp
CXAI
$4.89M
| $10.1K | ﹤0.01% |
120
+68
| +131% | +$7.07K |
2024 Q2
1 quarter
|
|
|
SHYF
13154
CALL
DELISTED
The Shyft Group
SHYF
| $10K | ﹤0.01% |
800
+100
| +14% | +$1.29K |
2020 Q3
16 quarters
|
|
13155
PUT
DocGo
DCGO
$36.1M
| $9.96K | ﹤0.01% |
3,000
-30,200
| -91% | -$103K |
2022 Q3
8 quarters
|
|
|
BPTH
13156
DELISTED
Bio-Path Holdings Inc
BPTH
| $9.93K | ﹤0.01% |
+10,917
| New | +$15K |
2024 Q3
0 quarters
|
|
13157
PUT
Community Trust Bancorp
CTBI
$1.38B
| $9.93K | ﹤0.01% |
200
-3,500
| -95% | -$167K |
2024 Q1
2 quarters
|
|
13158
Yunhong Green CTI Ltd
YHGJ
$7.04M
| $9.91K | ﹤0.01% |
+1,102
| New | +$10.4K |
2024 Q3
0 quarters
|
|
|
WBX
13159
PUT
Wallbox
WBX
$66.9M
| $9.88K | ﹤0.01% |
405
+395
| +3,950% | +$10.8K |
2024 Q1
2 quarters
|
|
13160
PUT
Quantum Computing Inc
QUBT
$1.8B
| $9.86K | ﹤0.01% |
15,100
+7,900
| +110% | +$5.05K |
2023 Q4
3 quarters
|
|
|
AVX
13161
Avax One Technology Ltd
AVX
$46.8M
| $9.82K | ﹤0.01% |
18
-14
| -44% | -$9.96K |
2024 Q2
1 quarter
|
|
13162
Siebert Financial
SIEB
$92.1M
| $9.8K | ﹤0.01% |
3,875
-701
| -15% | -$1.28K |
2024 Q1
2 quarters
|
|
13163
PUT
CytomX Therapeutics
CTMX
$562M
| $9.79K | ﹤0.01% |
8,300
+700
| +9% | +$889 |
2022 Q4
7 quarters
|
|
13164
PUT
iShares MSCI Pacific ex Japan ETF
EPP
$2.21B
| $9.77K | ﹤0.01% |
200
-500
| -71% | -$22.3K |
2022 Q3
8 quarters
|
|
13165
CALL
Oramed Pharmaceuticals
ORMP
$189M
| $9.76K | ﹤0.01% |
+4,000
| New | +$9.75K |
2024 Q3
0 quarters
|
|
13166
Alpha Pro Tech
APT
$58.7M
| $9.76K | ﹤0.01% |
1,712
-24,877
| -94% | -$144K |
2023 Q4
3 quarters
|
|
13167
AdvisorShares Psychedelics ETF
PSIL
$48.9M
| $9.75K | ﹤0.01% |
1,277
+1,046
| +453% | +$9.65K |
2024 Q2
1 quarter
|
|
13168
HeartSciences Inc Warrant
HSCSW
$174K
| $9.68K | ﹤0.01% |
220,428
-3,900
| -2% | -$165 |
2022 Q4
7 quarters
|
|
|
TBPH
13169
PUT
DELISTED
Theravance Biopharma
TBPH
| $9.67K | ﹤0.01% |
1,200
-1,900
| -61% | -$16.5K |
2023 Q4
3 quarters
|
|
13170
CALL
State Street SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$1.16B
| $9.66K | ﹤0.01% |
400
-1,300
| -76% | -$30.6K |
2023 Q3
4 quarters
|
|
13171
PUT
Washington Trust Bancorp
WASH
$727M
| $9.66K | ﹤0.01% |
300
-6,600
| -96% | -$202K |
2022 Q4
7 quarters
|
|
13172
PUT
Adicet Bio
ACET
$60.6M
| $9.65K | ﹤0.01% |
419
-319
| -43% | -$7.14K |
2022 Q3
8 quarters
|
|
13173
PUT
Kearny Financial
KRNY
$586M
| $9.62K | ﹤0.01% |
1,400
-2,100
| -60% | -$13.9K |
2022 Q4
7 quarters
|
|
13174
RUM Group Inc
RUM
$3.66B
| $9.6K | ﹤0.01% |
+1,791
| New | +$10.5K |
2024 Q3
0 quarters
|
|
|
PROF
13175
CALL
Profound Medical
PROF
$220M
| $9.55K | ﹤0.01% |
+1,200
| New | +$10.8K |
2024 Q3
0 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.